Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) [NA]

View source ↗

Summary

Clinical trial update for the DaRT alpha radiation emitter device from Alpha Tau Medical for treating skin cancer, oral cavity mucosal cancers, and superficial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cancer
• Skin Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• DaRT (alpha radiation emitter device)

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Skin Cancer, Mucosal Neoplasm of Oral Cavity | NA | Status: ACTIVE_NOT_RECRUITING